Embecta (EMBC) Income from Continuing Operations (2020 - 2026)
Embecta (EMBC) posted Income from Continuing Operations of 4100000.0 for Q1 2026, down 109.3% sequentially from 44100000.0 in Q4 2025, and down 117.45% YoY from 23500000.0 in Q1 2025.
Embecta (EMBC) Income from Continuing Operations (2020 - 2026) Analysis & Trends
Embecta has reported Income from Continuing Operations for 7 years, with the latest figure at 4100000.0 in Q1 2026.
- Quarterly Income from Continuing Operations fell 117.45% year-over-year to 4100000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 111900000.0 (up 111.93% YoY) and the FY2025 annual result came in at 95400000.0, up 21.84% from the prior year.
- Income from Continuing Operations declined to 4100000.0 in Q1 2026 per EMBC's latest filing, from 44100000.0 in the prior quarter.
- Over five years, Income from Continuing Operations peaked at 79600000.0 in Q1 2022 and troughed at 17200000.0 in Q3 2022.
- A 5-year average of 25556250.0 and a median of 21800000.0 in 2023 frame the typical range for Income from Continuing Operations.
- The sharpest annual moves came in 2022 and 2025: Income from Continuing Operations plunged 117.75% in 2022, then surged 209.52% in 2025.
- Over 5 years, Income from Continuing Operations stood at 35200000.0 in 2022, then sank by 42.9% to 20100000.0 in 2023, then dropped by 27.36% to 14600000.0 in 2024, then surged by 202.05% to 44100000.0 in 2025, then plunged by 109.3% to 4100000.0 in 2026.
- According to Business Quant data, Income from Continuing Operations over the past three periods registered 4100000.0, 44100000.0, and 26400000.0 for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Income (Continuing) (Qtr) |
|---|---|---|---|---|---|
| 1 | Intuitive Surgical | 134.13 Bn | 128.91 Bn | 1.96 Bn | 823.20 Mn |
| 2 | Becton Dickinson | 52.76 Bn | 51.90 Bn | 2.32 Bn | 452.00 Mn |
| 3 | Alcon | 35.81 Bn | 34.46 Bn | 1.68 Bn | - |
| 4 | Resmed | 33.72 Bn | 32.25 Bn | 861.22 Mn | 383.43 Mn |
| 5 | Medline | 29.38 Bn | 26.70 Bn | 2.22 Bn | 139.00 Mn |
| 6 | West Pharmaceutical Services | 25.00 Bn | 24.57 Bn | 329.20 Mn | 147.90 Mn |
| 7 | Solventum | 15.46 Bn | 15.06 Bn | 1.29 Bn | 93.00 Mn |
| 8 | Cooper Companies | 14.88 Bn | 14.74 Bn | 735.40 Mn | -77.90 Mn |
| 9 | Baxter International | 13.58 Bn | 11.43 Bn | 1.03 Bn | 135.00 Mn |
| 10 | Embecta | 305.26 Mn | 87.06 Mn | 153.30 Mn | 21.10 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 21.10 Mn |
| Mar 31, 2026 | -4.10 Mn |
| Dec 31, 2025 | 44.10 Mn |
| Sep 30, 2025 | 26.40 Mn |
| Jun 30, 2025 | 45.50 Mn |
| Mar 31, 2025 | 23.50 Mn |
| Sep 30, 2024 | 14.60 Mn |
| Jun 30, 2024 | 14.70 Mn |
| Mar 31, 2024 | 28.90 Mn |
| Dec 31, 2023 | 20.10 Mn |
| Sep 30, 2023 | 6.00 Mn |
| Jun 30, 2023 | 15.20 Mn |
| Mar 31, 2023 | 14.00 Mn |
| Dec 31, 2022 | 35.20 Mn |
| Sep 30, 2022 | -17.20 Mn |
| Jun 30, 2022 | 62.40 Mn |
| Mar 31, 2022 | 79.60 Mn |
| Dec 31, 2021 | 98.80 Mn |
| Sep 30, 2021 | 96.90 Mn |
| Jun 30, 2021 | 104.70 Mn |